SGP SpyGlass Pharma, Inc. Common Stock
USHealthcareAs of 2026-07-10 16:00
Why SGP matters now
SpyGlass Pharma, Inc. Common Stock (SGP) is a US stock in Healthcare. The latest InvestLog snapshot shows $22.52 with +12.21% on the session and $752.9M in market capitalization; recent performance reads 1-month -11.79% and YTD -29.17%.
The latest financial table shown here is Q1 2026, with revenue of $0.00, net income of $-13.8M, and EPS of $-0.69. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -3.8%.
The latest indexable market news headline is "SpyGlass Pharma Appoints Shannon Treviño as General Counsel" from GlobeNewsWire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $62.00. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
1.49
P/S
0.00
EV/EBITDA
-15.01
DCF Value
$2.77
FCF Yield
-3.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-123.5%
ROA
-10.2%
ROIC
-11.5%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $0.00 | $-13.8M | $-0.69 |
| Q4 2025 | $0.00 | $-12.6M | $-0.38 |
| FY 2025 | $0.00 | $-39.9M | $-1.19 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$62.00
Target (Median)
$62.00
Target Range
$62.00 - $62.00
Latest News
Company Info
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
—
Beta
-0.34
SpyGlass Pharma, Inc. is an advanced biopharmaceutical company dedicated to developing innovative therapeutic approaches for individuals suffering from chronic eye conditions. Its flagship investigational product, the Bimatoprost Drug Pad-IOL System (BIM-IOL System), is engineered for implantation during standard cataract removal procedures with the aim of reducing elevated intraocular pressure (IOP) in patients afflicted with either open-angle glaucoma (OAG) or ocular hypertension (OHT). Co-founded in January 2019 by Malik Y. Kahook and Glenn Sussman, the company maintains its headquarters in Aliso Viejo, CA.